Edna Mancilla
Pediatric Endocrinology · Philadelphia, PANPI 1427284314
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,500 of the $3,660 with a category attached, or 68.3%. Every reported general payment came from a single manufacturer, Ipsen Biopharmaceuticals, Inc.
Across 2 payments — averaging $1830.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ipsen Biopharmaceuticals, Inc$4K
Across 441 payments — averaging $5201.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ipsen Bioscience Inc.$1M
- Incyte Corporation$974K
- Ipsen Innovation$178K
- Ipsen Pharma SAS$107K
- Ipsen Biopharmaceuticals, Inc$21K
What the payments were for
- Consulting fees$1,16032%
- Education$2,50068%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 2 | $3,660 |
How this compares
$3,660 in reported general payments places this provider in the 70th percentile of 80 pediatric endocrinology providers in Pennsylvania.
Other pediatric endocrinology in Philadelphia
- Michael LevinePhiladelphia$128K
- Craig AlterPhiladelphia$102K
- Judith RossPhiladelphia$75K
- Julia CrowleyPhiladelphia$75K
- Steven WilliPhiladelphia$34K
- Andrew BauerPhiladelphia$34K
- David WeberPhiladelphia$24K
- Diva DeleonPhiladelphia$21K
- Andrew CalabriaPhiladelphia$20K
- Maria VogiatziPhiladelphia$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.